| Name | N-{2-[(2-Oxo-3-azepanyl)carbamoyl]phenyl}-1-benzothiophene-2-carb oxamide |
|---|---|
| Synonyms |
ANA12 //BP
N-[2-[[(Hexahydro-2-oxo-1H-azin-3-yl)amino]carbonyl]phenyl]-benzo[b]thiophene-2-cboxamide ANA 12;ANA12 N-(2-((2-oxoazan-3-yl)cbamoyl)phenyl)benzo[b]thiophene-2-cboxamide Obatoclax (GX15-070) mesylate N-{2-[(2-OXO-3-AZANYL)CBAMOYL]PHENYL}-1-BENZOTHIOPHENE-2-CB OXAMIDE Benzo[b]thiophene-2-cboxamide, N-[2-[[(hexahydro-2-oxo-1H-azin-3-yl)amino]carbonyl]phenyl] ANA12 ANA-12, TrkB antagonist ANA-12, 10 mM in DMSO TrkB Antagonist, ANA-12 |
| Description | ANA-12 is a potent and selective TrkB antagonist with IC50s of 45.6 nM and 41.1 μM for the high and low affinity sites, respectively. |
|---|---|
| Related Catalog | |
| In Vitro | ANA-12 (10 nM) prevents BDNF-induced neurite outgrowth in the TrkB-expressing cells, and completely abolishes the effects of BDNF at concentrations up to 10-100 μM[1]. |
| In Vivo | ANA-12 (0.5 mg/kg, i.p.) partially inhibits the total endogenous TrkB activity in the whole brain of mice. ANA-12, injected in mice, demonstrates anxiolytic and antidepressive activities at 0.5 mg/kg. ANA-12 (0.5, 1.0, and 2.0 mg/kg) does not affect neuron survival[1]. ANA-12 (0.5 mg/kg) shows antidepressant effects in lipopolysaccharide (LPS)-induced depression-like behavior. ANA-12 (0.5 mg/kg) significantly attenuates an increased immobility time in depressed mice. In the TST, FST, and SPT, ANA-12 (0.5 mg/kg) does not show antidepressant-like effects in the control mice[2]. ANA-12 (0.5 mg/kg, i.p.) reverses the diminished self-administration of cocaine in CocSired rats[3]. |
| Animal Admin | On the day of injection, ketamine (ketamine hydrochloride, 10 mg/kg), 7,8-dihydroxyflavone (7,8-DHF; 10 mg/kg), and ANA-12, N2-(2-{[(2-oxoazepan-3-yl) amino]carbonyl}phenyl)benzo[b]thiophene-2-carboxamide (0.5 mg/kg) are prepared in vehicle of 17 % dimethyl sulfoxide (DMSO) in phosphate-buffered saline. The doses of ketamine (10 mg/kg), 7,8-DHF (10 mg/kg), and ANA-12 (0.5 mg/kg) are selected. All compounds are administered intraperitoneally (i.p.) to mice. |
| References |
| Molecular Formula | C22H21N3O3S |
|---|---|
| Molecular Weight | 407.48500 |
| Exact Mass | 407.13000 |
| PSA | 126.01000 |
| LogP | 4.78680 |
| Appearance | white to beige |
| Storage condition | 2-8°C |
| Water Solubility | DMSO: ≥5mg/mL at 60°C |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Hazard Codes | Xn |
| Risk Phrases | 22 |
| RIDADR | NONH for all modes of transport |